Source: Eur Respir J 2014; 43: 421-429
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Iwamoto Hiroshi, Gao Jing, Koskela Jukka, Kinnula Vuokko, Kobayashi Hideo, Laitinen Tarja, Mazur Witold. Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap. Eur Respir J 2014; 43: 421-429

Member's Comments

No comment yet.

Related content which might interest you: Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Blood biomarkers in asthma and COPD Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017 COPD assessment test correlation with the increase of the inflammatory markers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 COPD and asthma overlap with bronchiectasis Source: Eur Respir Monogr 2018; 81: 167-185 Year: 2018 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002